NUTRACEUTICALS - A REGULATORY REVIEW
Journal Title: International Journal of Drug Regulatory Affairs - Year 2015, Vol 3, Issue 2
Abstract
The Nutraceuticals are the emerging sector in the Pharma Industry. As people are more and more concerned about their health and diseases caused by the malnutrition, the growth of the Nutraceuticals worldwide are inevitable. Despite of the growth and the need of the Nutraceuticals by global market there is no apparent regulatory definitions and pathways or procedures for the approval process of Nutraceuticals. The article deals with the regulatory perspective of Nutraceuticals.
Authors and Affiliations
Ganesh GNK, Ramachandran A, Suresh KR, Senthil V, Baviya Priyadharshini R
Keywords
Related Articles
- EP ID EP339366
- DOI -
- Views 129
- Downloads 0
A retrospective study of Warning Letters issued by US FDA over 2015-2017
This paper provides contemporary climate of warning letters issued by US FDA over 2015 to 2017. With 1300$ Billion Revenue in 2017 United States stands as World’s largest Pharmaceutical Market. Being the largest, diversi...
Registration of Drug Product dossier application as per EU Guidelines
Due to variations in the regulatory norms of registration dossier in different countries, there is a strong need for harmonization by ICH for approval of drugs. Generic drugs in EU are approved under the Marketing Author...
Comparative study of the harmonization of pharmaceutical regulations in the western and central sub-regions of Africa
The harmonization of pharmaceutical regulations in Africa aims to offer States a coherent body of texts and practices by combining limited resources. The objective of this study was to describe policies to harmonize phar...
Regulatory overview of biosimilars in Europe
A biosimilar is a biological medicine similar, but not identical, to an already registered reference bio therapeutic product in terms of quality, safety, and efficacy. These drugs are also called as biosimilar products„,...
COMPARISON OF GLOBAL REGULATORY GUIDELINES FOR AVAILABILITY OF DIFFERENT BIOWAIVER PROVISIONS AND APPLICATION REQUIREMENTS OF BIOPHARMACEUTICS CLASSIFICATION SYSTEM (BCS) BASED BIOWAIVER.
To waive a complete and systemic Bioequivalence (BE) study, Biowaiver or Request for a Biowaiver is a fast track approach to boost the drug development process. Over the past three-four years the Biowaiver market shows g...